01477.HK
Ocumension Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 4.79
+3.90%Margins
Gross margin
47.2%
EBITDA margin
2.9%
EBIT margin
-13.3%
Net margin
-13.4%
FCF margin
-29.4%
-3.5%
Return on equity
-3.0%
Return on assets
-3.2%
Return on invested capital
0.23x
Asset turnover
-HKD 15.1M
Cash from operations
HKD 0.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026